Why CVS Health Stock Is Soaring Today
Werte in diesem Artikel
Shares of pharmacy and insurance giant CVS Health (NYSE: CVS) were soaring 8.2% higher as of 11:32 a.m. ET on Tuesday. Part of the gain undoubtedly related to the overall market's rebound following a steep sell-off on worries about the potential impact of tariffs. However, CVS Health's corporate update on Tuesday was likely a factor behind the stock's jump, too.CVS Health announced that Brian Newman will be the new CFO effective April 21, 2025. Newman is coming to CVS after serving as CFO for United Parcel Service. CVS Health's current CFO, Tom Cowhey, will move into a role as strategic advisor to CEO David Joyner on May 12, 2025. The company also named Amy Compton-Phillips as its new chief medical officer. She most recently served as chief physician executive of healthcare performance improvement company Press Ganey. Sometimes changes in the executive ranks provide a catalyst for a stock, especially when the moves involve CEOs or CFOs. In this case, though, I don't think the announcements of Newman as CFO or Compton-Phillips as chief medical officer were the key drivers of CVS Health's nice gain today. Both have solid experience and will likely be great additions to CVS Health. However, the most important news in CVS Health's update wasn't related to leadership changes, in my opinion.Continue readingWeiter zum vollständigen Artikel bei MotleyFool
Übrigens: CVS Health und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und als Geschenk eine Gratisaktie erhalten.
Ausgewählte Hebelprodukte auf CVS Health
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf CVS Health
Der Hebel muss zwischen 2 und 20 liegen
Name | Hebel | KO | Emittent |
---|
Name | Hebel | KO | Emittent |
---|
Quelle: MotleyFool
Nachrichten zu CVS Health Corp
Analysen zu CVS Health Corp
Datum | Rating | Analyst | |
---|---|---|---|
05.06.2019 | CVS Health Buy | Standpoint Research | |
15.04.2019 | CVS Health Perform | Oppenheimer & Co. Inc. | |
12.04.2019 | CVS Health Market Perform | BMO Capital Markets | |
18.12.2018 | CVS Health Overweight | Barclays Capital | |
26.10.2018 | CVS Health Peer Perform | Wolfe Research |
Datum | Rating | Analyst | |
---|---|---|---|
05.06.2019 | CVS Health Buy | Standpoint Research | |
12.04.2019 | CVS Health Market Perform | BMO Capital Markets | |
18.12.2018 | CVS Health Overweight | Barclays Capital | |
30.01.2018 | CVS Health Strong Buy | Needham & Company, LLC | |
02.01.2018 | CVS Health Buy | Needham & Company, LLC |
Datum | Rating | Analyst | |
---|---|---|---|
15.04.2019 | CVS Health Perform | Oppenheimer & Co. Inc. | |
26.10.2018 | CVS Health Peer Perform | Wolfe Research | |
28.06.2017 | CVS Health Hold | Needham & Company, LLC | |
02.02.2017 | CVS Health Neutral | Robert W. Baird & Co. Incorporated | |
22.06.2016 | CVS Health Hold | Deutsche Bank AG |
Datum | Rating | Analyst | |
---|---|---|---|
25.07.2005 | Update Longs Drug Stores Corp.: Underperform | Bear Stearns |
Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für CVS Health Corp nach folgenden Kriterien zu filtern.
Alle: Alle Empfehlungen